Intimation of Change in name of Managing Director of the Company.
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kwality Pharmaceuticals has informed BSE that its Managing Director Ramesh Arora has changed his name to Ramesh Kumar. The company filed Form DIR-6 with the Ministry of Corporate Affairs to update the name in MCA records. The company has clarified that this is purely a name correction with no change in designation, terms of appointment, or any other details of the director.
This is a routine administrative/corrective disclosure and has no material impact on the company's operations, governance, or shareholder value. It is essentially the same person serving as Managing Director under a corrected name.